Upstate Medical University will break ground on a new Upstate Cancer Center in Verona Oct. 20.
The ceremony will mark the beginning of construction on a gleaming new 30,000 square foot facility that will bring comprehensive cancer care closer to home for residents of Madison and Oneida counties.
The facility will provide expanded diagnostic and treatment services in a convenient location just off Exit 33 of the New York State Thruway. Upstate’s existing cancer center on Seneca Street in Oneida, about 15 minutes away, will relocate to Verona when the new office opens.
“We’re very enthusiastic about this beautiful new facility that will improve access to the outstanding cancer care and expertise that Upstate offers to patients throughout Central New York,” said Thomas Vandermeer, MD, FACS, interim director of the Upstate Cancer Center. “This new center will enable Upstate to expand the comprehensive, state-of-the-art cancer services that we provide at the Upstate Cancer Center in Syracuse to Verona. We will now be able to offer this level of care closer to home for many of our patients in Central New York.”
The Upstate Center and its satellite branches recorded more than 100,000 patient visits in 2020.
The Upstate Cancer Center at Verona will offer medical oncology, radiation therapy, surgical subspecialties, radiology, laboratory, pharmacy and consultative services similar to those found at the Upstate Cancer Center in downtown Syracuse. Whether in Syracuse, Oswego, Oneida or Verona, Upstate patients have access to the latest cancer-fighting technology and clinical trials not available anywhere else in the region.
The Verona site, which will be more than twice the size of the Upstate Cancer Center at Oneida, will continue Upstate’s tradition of offering multidisciplinary care with a team of experts that includes surgeons, medical oncologists, radiation oncologists and other specialists who consult together to manage each patient’s specific treatment.
The Upstate Cancer Center at Verona is expected to open in early 2023.